Pfizer/Sanofi Exubera Effective For Both Type 1 And Type 2 Diabetes, Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee rejects FDA contention that inhaled insulin may not have shown intensive glycemic control in Type 1 diabetes.